The aim of this study was to determine the efficacy elicited by ERYSENG® PARVO, a new inactivated Porcine Parvovirus (PPV) and Erysipelothrix rhusiopathiae vaccine after challenge with pathogenic swine E. rhusiopathiae strains in gilts and boars.
Efficacy against erysipelas conferred by ERYSENG® PARVO
Publications
Swine
Appeared in
IPVS Congress, 2014
Download this article
Related products
The first intradermal needle-free vaccine against Mycoplasma hyopneumoniae and PCV2, all in one, in suspension for injection
Live vaccine against porcine reproductive and respiratory syndrome (PRRS), in injectable freeze-dried tablet
Purified recombinant verotoxin 2e against edema disease, in suspension for injection
Inactivated vaccine, against progressive and non progressive swine atrophic rhinitis, in injectable suspension.
Inactivated vaccine against neonatal colibacillosis and Clostridium infections in swine, in injectable suspension
Inactivated vaccine against Clostridioides difficile and Clostridium perfringens type A infections in swine, in injectable suspension.
Inactivated vaccine against porcine parvovirus and swine erysipelas, in injectable suspension
Inactivated vaccine against swine erysipelas, parvovirosis and leptospirosis, in injectable suspension
Live vaccine against Aujeszky’s disease gE negative strain, in injectable freeze-dried tablet
Inactivated vaccine against swine erysipelas, in injectable suspension
Inactivated porcine against porcine parvovirus, in injectable suspension
Inactivated vaccine against enzootic pneumonia, in injectable suspension
Related services
An innovative service based on data analysis that facilitates decision-making in swine
HIPRA Stats is a data analysis service for animal production companies.
HIPRA University offers high quality training programmes in strategic areas of interest for professionals
Access an advanced diagnostic service with maximum comfort and reliability
